Press Release

Anne-Catherine Berner, new Grifols Chair

Read Release

Image Gallery

Get a set of ready-to-use images

Download

2025 Shareholders' Meeting resolutions approved

Grifols’ shareholders have approved all the items on the agenda submitted for approval at the 2025 Annual General Shareholders' Meeting including the following:

  • The reelection of Víctor Grifols Deu as a member of the Board of Directors.
  • The ratification of Pascal Ravery as an independent director.
  • The designation of Paul S. Herendeen as a proprietary director by shareholders Flat Footed, Mason Capital and Sachem Head.
  • The reduction of the number of members of Board members to 12.
  • The endorsement of the company’s directors' remuneration policy and stock incentive plan for 2025.
  • The shareholders' endorsement of the 2024 financial statements, in which the company exceeded forecasts with revenues reaching €7,212 million.

Anne-Catherine Berner has been appointed new Grifols' non-executive Chair, succeeding outgoing Chairman Thomas Glanzmann, after the General Shareholders' Meeting.

"As president, I will work to uphold the highest standards of quality, rigor, transparency, and governance that define the company, and I will safeguard the best interests of our patients and donors, always with a long-term vision."

Anne-Catherine Berner, Grifols Non-executive Chair

Direct links